Literature DB >> 31954997

Invoking death: How oncologists discuss a deadly outcome.

Alexandra Tate1.   

Abstract

Existing sociological research documents patient and physician reticence to discuss death in the context of a patient's end of life. This study offers a new approach to analyzing how death gets discussed in medical interaction. Using a corpus of 90 video-recorded oncology visits and conversation analytic (CA) methods, this analysis reveals that when existing parameters are expanded to look at mentions of death outside of the end-of-life context, physicians do discuss death with their patients. Specifically, the most frequent way physicians invoke death is in a persuasive context during treatment recommendation discussions. When patients demonstrate active or passive resistance to a recommendation, physicians invoke the possibility of the patient's death to push back against this resistance and lobby for treatment. Occasionally, physicians invoke death in instances where resistance is anticipated but never actualized. Similarly, death invocations function for treatment advocacy. Ultimately, this study concludes that physicians in these data invoke death to leverage their professional authority for particular treatment outcomes.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Conversation analysis; Decision-making; Doctor-patient interaction

Year:  2019        PMID: 31954997      PMCID: PMC7034306          DOI: 10.1016/j.socscimed.2019.112672

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  35 in total

1.  Shared decision making--pinnacle of patient-centered care.

Authors:  Michael J Barry; Susan Edgman-Levitan
Journal:  N Engl J Med       Date:  2012-03-01       Impact factor: 91.245

2.  Connected health and the rise of the patient-consumer.

Authors:  William H Frist
Journal:  Health Aff (Millwood)       Date:  2014-02       Impact factor: 6.301

3.  Characterizing the Nature of Scan Results Discussions: Insights Into Why Patients Misunderstand Their Prognosis.

Authors:  Sarguni Singh; Dagoberto Cortez; Douglas Maynard; James F Cleary; Lori DuBenske; Toby C Campbell
Journal:  J Oncol Pract       Date:  2017-01-17       Impact factor: 3.840

Review 4.  Shared decision making in clinical medicine: past research and future directions.

Authors:  D L Frosch; R M Kaplan
Journal:  Am J Prev Med       Date:  1999-11       Impact factor: 5.043

Review 5.  Examining critical health policy issues within and beyond the clinical encounter: patient-provider relationships and help-seeking behaviors.

Authors:  Carol A Boyer; Karen E Lutfey
Journal:  J Health Soc Behav       Date:  2010

6.  Creating space to discuss end-of-life issues in cancer care.

Authors:  Dagoberto Cortez; Douglas W Maynard; Toby C Campbell
Journal:  Patient Educ Couns       Date:  2018-07-06

Review 7.  Informed consent and patient decision making: two decades of research.

Authors:  C L Kaufmann
Journal:  Soc Sci Med       Date:  1983       Impact factor: 4.634

8.  'Breast cancer won't kill ya in the breast': Broaching a rationale for chemotherapy during the surgical consultation for early-stage breast cancer.

Authors:  Virginia Teas Gill
Journal:  Patient Educ Couns       Date:  2018-09-05

9.  Treatment Recommendations in Oncology Visits: Implications for Patient Agency and Physician Authority.

Authors:  Alexandra Tate
Journal:  Health Commun       Date:  2018-09-05

10.  Offering patients choices: a pilot study of interactions in the seizure clinic.

Authors:  Merran Toerien; Rebecca Shaw; Roderick Duncan; Markus Reuber
Journal:  Epilepsy Behav       Date:  2011-01-15       Impact factor: 2.937

View more
  1 in total

Review 1.  Communicating with patients and families about illness progression and end of life: a review of studies using direct observation of clinical practice.

Authors:  Stuart Ekberg; Ruth Parry; Victoria Land; Katie Ekberg; Marco Pino; Charles Antaki; Laura Jenkins; Becky Whittaker
Journal:  BMC Palliat Care       Date:  2021-12-08       Impact factor: 3.234

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.